We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

COPAN DIAGNOSTICS

COPAN (which stands for COllection and Preservation for ANalysis) is a global market leader in sample collection and ... read more Featured Products: More products

Download Mobile App




Alternative Methods Compared for Urine Culture Collection and Transport

By LabMedica International staff writers
Posted on 24 Aug 2016
The ability to isolate and identify causative agents of urinary tract infections relies primarily on the quality of the urine sample that is submitted to the microbiology laboratory.

Quantitation, identification and antimicrobial susceptibility testing is predicated on initial appropriate collection, ensuring that transport is performed in such a way as to preserve the right pathogen at the correct concentration, and third, that what is assumed to be the pathogen is actually causing an infection.

Microbiologists at the University of Alberta Hospital (Edmonton, AB, Canada) have reported a composite of several investigations comparing collection and transport on urine culture paddles, with a preservative urine sponge and a comparison of the urine sponge with a preservative transport tube as methods of preservation of urinary pathogens. More...
Aside from the bedside issues of collection of mid-stream urines, samples from catheterized patients, and infants, there are concerns for transport of the sample to the laboratory to avoid overgrowth (or loss) of the causative organism.

The scientists used two devices as method of transport; the Becton Dickinson Urine Vacutainer, sometimes called a “Grey-Vac” (BD, Towson, MD, USA) and the Copan Uriswab (Copan Innovations, Brescia, Italy). In the Grey-Vac, urine is poured or transferred into the tube that contains a preservative pill and urine volume must reach the line on the tube (approximately 4 mL). In the Uriswab method, preservative is impregnated into the sponge, and the sponge is either dipped into the urine to saturate the sponge, or the patient may urinate directly onto the sponge. The Uriswab sponge holds approximately 1.5 mL. For collection of urine on the culture paddle, urine is collected into a sterile container. Morphotypes were quantitated and identification of uro-pathogens was made using either Vitek 2 (bioMérieux, Marcy-l'Étoile, France) GNI or GPI cards or with other validated non-automated methods.

The scientists reported that there were 25 more potential pathogen isolates recovered from the Uriswab than the culture paddle. Particularly for Escherichia coli, 10 additional isolates were identified from Uriswab, and there were no β-hemolytic streptococci recovered from the culture paddle. There were no significant differences in the number of different species recovered from both transport devices. An additional three E. coli were recovered at significant concentrations from Uriswab that were not observed in the Grey-Vac portion of the same urine sample.

The authors concluded that the isolation of urinary pathogens from sites both remote and close to the testing laboratory was enhanced by collection on the Uriswab compared both to culture paddle cultures and to the Grey-Vac preservative transport device. Costs for the culture paddle method become greater than either the Uriswab or the Grey-Vac because of the number of mixed cultures on the dip slides that need to be sub-cultured before determining if the isolates are significant to the infectious process. The study was published in the August 2016 issue of the journal Diagnostic Microbiology and Infectious Disease.

Related Links:
University of Alberta Hospital
BD
Copan Innovations
bioMérieux

New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Serological Pipet Controller
PIPETBOY GENIUS
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: New research brings hope for improved early detection of pancreatic cancer (Photo courtesy of Adobe Stock)

New Biomarker Panel to Enable Early Detection of Pancreatic Cancer

Pancreatic cancer (PC) has one of the worst prognoses globally, with only 13% of diagnosed patients surviving for five years or more. In Ireland, there are about 900 cases of pancreatic cancer annually,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.